Perspectives on current survival and new developments in AML
- PMID: 33762103
- DOI: 10.1016/j.beha.2021.101248
Perspectives on current survival and new developments in AML
Abstract
The past three years have witnessed remarkable progress in acute myeloid leukemia (AML). The approval and development of targeted therapies and novel agents has improved outcomes for patients with traditionally poor survival rates. This review has summarized the survival impact of chemotherapy-based regimens in AML and described recent advances that will be of significance in the near future.
Keywords: AML; APR246; Acute myeloid leukemia; Aspacytarabine; BSP-236; CC-486; Eprenetapopt; OS; Oral azacitidine; Overall survival; Venetoclax.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
